82 followers
82 followers
1,980 followers
@Karl_Lauterbach Razi Cov Pars, ein vom iranischen Razi Vaccine and Serum Research Institute entwickelter COVID-19-Impfstoff, erfordert drei Dosen, die intramuskulär und intranasal verabreicht werden. Es befindet sich derzeit in Phase III der klinischen Fo
18,618 followers
Safety and Efficacy of Combined Intramuscular/Intranasal RAZI-COV PARS Vaccine Candidate Against SARS-CoV-2: A Preclinical Study in Several Animal Models: Several vaccine candidates for COVID-19 have been developed, and few #immunology… https://t.co/VZEg6